{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:49:06Z","timestamp":1793364546555,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","academicradiology.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.acra.2024.09.036","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T22:42:53Z","timestamp":1729809773000},"page":"821-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Coupling Habitat Radiomic Analysis with the Diversification of the Tumor ecosystem: Illuminating New Strategy in the Assessment of Postoperative Recurrence of Non-Muscle Invasive Bladder Cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Hong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongli","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5092-6448","authenticated-orcid":false,"given":"Yiheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.acra.2024.09.036_bib1","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.acra.2024.09.036_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective","volume":"19","author":"Teoh","year":"2022","journal-title":"Nat Rev Urol"},{"issue":"4","key":"10.1016\/j.acra.2024.09.036_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000533410","article-title":"Analysis of risk factors for recurrence after transurethral resection of bladder tumor in patients with non-muscle invasive bladder cancer: 2-year follow-up outcomes","volume":"102","author":"Li","year":"2024","journal-title":"Oncology"},{"key":"10.1016\/j.acra.2024.09.036_bib4","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.acra.2024.09.036_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.urolonc.2022.06.008","article-title":"Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer","volume":"40","author":"Krajewski","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acra.2024.09.036_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102352","article-title":"Deep learning signature based on multiphase enhanced CT for bladder cancer recurrence prediction: a multi-center study","volume":"66","author":"Wang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.acra.2024.09.036_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ebiom.2019.05.023","article-title":"Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy","volume":"44","author":"Xie","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.acra.2024.09.036_bib8","article-title":"Habitat radiomics analysis of pet\/ct imaging in high-grade serous ovarian cancer: application to Ki-67 status and progression-free survival","volume":"13","author":"Wang","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.acra.2024.09.036_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.833578","article-title":"Dynamic changes in myofibroblasts affect the carcinogenesis and prognosis of bladder cancer associated with tumor microenvironment remodeling","volume":"10","author":"Du","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.acra.2024.09.036_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257195","article-title":"Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer","volume":"16","author":"Muilwijk","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.acra.2024.09.036_bib11","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1007\/s00330-021-08426-3","article-title":"CT-based radiomics to predict muscle invasion in bladder cancer","volume":"32","author":"Zhang","year":"2022","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.acra.2024.09.036_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.acra.2024.09.036_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 Classification Systems for Grade: an update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.acra.2024.09.036_bib14","article-title":"MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer","volume":"308","author":"Shi","year":"2023","journal-title":"Radiology"},{"issue":"21","key":"10.1016\/j.acra.2024.09.036_bib15","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.acra.2024.09.036_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101899","article-title":"Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study","volume":"58","author":"Huang","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.acra.2024.09.036_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/2632010X21989686","article-title":"Standardized assessment of the tumor-stroma ratio in colorectal cancer: interobserver validation and reproducibility of a potential prognostic factor","volume":"14","author":"Souza da Silva","year":"2021","journal-title":"Clin Pathol"},{"key":"10.1016\/j.acra.2024.09.036_bib18","article-title":"Differentiation of muscular invasion in bladder cancer: additional value of synthetic magnetic resonance imaging","author":"Zhang","year":"2024","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2024.09.036_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.899897","article-title":"Feasibility study on predicting recurrence risk of bladder cancer based on radiomics features of multiphase CT images","volume":"12","author":"Qian","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2024.09.036_bib20","article-title":"Prospective comparison of 2D and 3D T2-weighted imaging in multiparametric MRI for assessing muscle invasion accuracy using VI-RADS in bladder cancer","author":"Zhang","year":"2024","journal-title":"Acad Radiol"},{"issue":"17","key":"10.1016\/j.acra.2024.09.036_bib21","article-title":"Survival prediction of patients with bladder cancer after cystectomy based on clinical, radiomics, and deep-learning descriptors","volume":"15","author":"Sun","year":"2023","journal-title":"Cancers ((Basel))"},{"issue":"8","key":"10.1016\/j.acra.2024.09.036_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00262-024-03724-3","article-title":"Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients","volume":"73","author":"Caii","year":"2024","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"10.1016\/j.acra.2024.09.036_bib23","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1007\/s00330-020-07560-8","article-title":"Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer","volume":"31","author":"Beer","year":"2021","journal-title":"Eur Radiol"},{"issue":"22","key":"10.1016\/j.acra.2024.09.036_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214481","article-title":"Utility of a molecular signature for predicting recurrence and progression in non-muscle-invasive bladder cancer patients: comparison with the EORTC, CUETO and 2021 EAU Risk Groups","volume":"23","author":"Piao","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.acra.2024.09.036_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13073-021-00968-x","article-title":"Deep learning in cancer diagnosis, prognosis and treatment selection","volume":"13","author":"Tran","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.acra.2024.09.036_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105152","article-title":"Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer","volume":"104","author":"Liu","year":"2024","journal-title":"EBioMedicine"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224006858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224006858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:30:57Z","timestamp":1738999857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633224006858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1076633224006858"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2024.09.036","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coupling Habitat Radiomic Analysis with the Diversification of the Tumor ecosystem: Illuminating New Strategy in the Assessment of Postoperative Recurrence of Non-Muscle Invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2024.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}